Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationHematopoietic Stem CellsHematologic NeoplasmsBone Marrow TransplantationMyeloablative AgonistsCord Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationWhole-Body IrradiationBone MarrowBone Marrow CellsTransplantation ChimeraTissue DonorsUnrelated DonorsGraft SurvivalEmbryonic Stem CellsHistocompatibility TestingTreatment OutcomeHistocompatibilityAdult Stem CellsBusulfanAntigens, CD34Granulocyte Colony-Stimulating FactorVidarabineHematopoiesisCell DifferentiationLeukemiaLiver TransplantationRecurrenceMesenchymal Stem Cell TransplantationPluripotent Stem CellsRetrospective StudiesLeukapheresisLeukemia, Myeloid, AcuteCombined Modality TherapyRemission InductionGraft vs Tumor EffectImmunosuppressive AgentsStem Cell NicheMultiple MyelomaSurvival AnalysisChimerismCyclophosphamideSiblingsGraft vs Leukemia EffectDisease-Free SurvivalSurvival RateNeural Stem CellsTime FactorsHLA AntigensCell TransplantationInduced Pluripotent Stem CellsMelphalanMyelodysplastic SyndromesStem Cell FactorBlood Component RemovalDonor SelectionHematologic DiseasesCell LineageMultipotent Stem CellsLymphoma, Non-HodgkinKidney TransplantationFetal BloodMesenchymal Stromal CellsAntineoplastic Combined Chemotherapy ProtocolsTransplantation ImmunologyGraft RejectionCells, CulturedAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayBlood CellsFollow-Up StudiesMice, Inbred C57BLAcute DiseaseCyclosporineTransplantationImmunosuppressionCell SeparationSalvage TherapyLymphocyte TransfusionT-LymphocytesAntilymphocyte SerumCytomegalovirus InfectionsHeart TransplantationTransplantation, IsogeneicFetal Stem CellsInfectionLymphocyte DepletionHepatic Veno-Occlusive DiseaseHodgkin DiseaseDirected Tissue Donation